Lucira Health says COVID-19 test detects Omicron variant, shares up

Lucira Health

29/11/2021 14:16

** Shares of medical technology co  LHDX.O  rise 3.3% to
$7.21 premarket
    ** Company says its at-home, molecular test kits can detect
the new coronavirus Omicron variant  urn:newsml:reuters.com:*:nGNXG2dLt
    ** Says its evaluation demonstrated that the tests can
detect 100% of genome sequences of the new variant that were
analyzed
    ** The heavily mutated Omicron variant is likely to spread
internationally and poses a very high risk of infection surges
that could have "severe consequences" in some places - World
Health Organization  urn:newsml:reuters.com:*:nL1N2SK0EY
    ** Stock down 72%, as of last close, since company's market
debut in February

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))